Recent evidence shows that SARS-COV2 infection could become a significant risk factor for
dementia, in addition to aging, due to the virus' damage to the brain ( Toniolo et al., 2021) …

Emerging evidence indicates that the etiologic agent responsible for coronavirus disease
2019 (COVID-19), can cause neurological complications. COVID-19 may induce cognitive …

It is becoming increasingly clear that the worldwide outbreak of severe acute respiratory
syndrome coronavirus 2 will have long-term negative consequences. Some patients report …

We thank Guedj and colleagues 1 for their positive comment on our recent study on
cognitive impairment and altered cerebral glucose metabolism in COVID-19. 2 In our study …

Cognitive impairment is a primary manifestation of neurological symptoms associated with
COVID-19 and may occur after disease resolution. Although cognitive impairment has been …

Caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), coronavirus
disease 2019 (COVID‐19) primarily manifests as respiratory dysfunction. However …

Acute delirium and other neuropsychiatric symptoms have frequently been reported in
COVID-19 patients and are variably referred to as acute encephalopathy, COVID-19 …

COVID-19 affects brain function, as deduced by the “brain fog” that is often encountered in
COVID-19 patients and some cognitive impairment that is observed in many a patient in the …

Purpose Little is known about the neuronal substrates of neuropsychiatric symptoms
associated with COVID-19 and their evolution during the course of the disease. We aimed at …

Purpose A hypometabolic profile involving the limbic areas, brainstem and cerebellum has
been identified in long COVID patients using [18F] fluorodeoxyglucose (FDG)-PET. This …